| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |